Overview
Taekeun Oh practices practicing medicine in Incheon, Republic of Korea.
Their clinical expertise encompasses Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, Low Blood Sugar, and Diabetic Retinopathy.
They are actively involved in clinical research, co-authoring 21 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Taekeun K. Oh
Is Taekeun K. Oh a top-rated expert for Type 2 Diabetes (T2D)?
MediFind is an objective health platform that identifies experts based on real-world data. Taekeun K. Oh is classified as an Experienced expert for Type 2 Diabetes (T2D), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Taekeun K. Oh participate in research or clinical trials?
Yes. Taekeun K. Oh has published 21 articles and abstracts on conditions like Type 2 Diabetes (T2D). You can view a list of Taekeun K. Oh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Diabetic RetinopathyOh isExperienced. Learn about Diabetic Retinopathy.
- Low Blood SugarOh isExperienced. Learn about Low Blood Sugar.
- Maturity Onset Diabetes of the Young
- Type 2 Diabetes (T2D)Oh isExperienced. Learn about Type 2 Diabetes (T2D).